A novel and portable extracorporeal CO2-removal device was evaluated to provide additional gas transfer, auxiliary to standard therapy in severe acute hypercapnic respiratory failure. A dual-lumen catheter was inserted percutaneously in five subjects (mean age 55±0.4 years) and, subsequently, connected to the CO2-removal device. The median duration on support was 45 hours (interquartile range 26-156), with a blood flow rate of approximately 500 mL/min. The mean PaCO2 decreased from 95.8±21.9 mmHg to 63.9±19.6 mmHg with the pH improving from 7.11±0.1 to 7.26±0.1 in the initial 4 hours of support. Three subjects were directly weaned from the CO2-removal device and mechanical ventilation, one subject was converted to ECMO and one subject died following withdrawal of support. No systemic bleeding or device complications were observed. Low-flow CO2 removal adjuvant to standard therapy was effective in steadily removing CO2, limiting the progression of acidosis in subjects with severe acute hypercapnic respiratory failure.
Global Strategy for the Diagnosis MaPoC, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2014. Available from: http://www.goldcopd.org/.<GOLD_Report2014_Feb07.pdf>
2.
MikkelsenMEDedhiyaPMKalhanR. Potential reasons why physicians underuse lung-protective ventilation: a retrospective cohort study using physician documentation. Respir Care2008; 53: 455–461.
3.
BrunoCMValentiM. Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. J Biomed Biotechnol2012; 2012: 915150.
4.
PhuaJKongKLeeKH. Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure. Intensive Care Med2005; 31: 533–539.
5.
ConfalonieriMGarutiGCattaruzzaMS. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J2005; 25: 348–355.
6.
QuinnellTGPilsworthSShneersonJM. Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest2006; 129: 133–139.
7.
ConnorsAFJr.DawsonNVThomasC. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med1996; 154: 959–967.
8.
PeekGJMugfordMTiruvoipatiR. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet2009; 374: 1351–1363.
9.
LundLWFederspielWJ. Removing extra CO2 in COPD patients. Curr Respir Care Rep2013; 2: 131–138.
10.
GattinoniLKolobowTDamiaG. Extracorporeal carbon dioxide removal (ECCO2R): a new form of respiratory assistance. Int J Artif Organs1979; 2: 183–185.
11.
GattinoniLPesentiAMascheroniD. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA1986; 256: 881–886.
12.
MorrisAHWallaceCJMenloveRL. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med1994; 149: 295–305.
13.
KnochMKollenBDietrichG. Progress in veno-venous long-term bypass techniques for the treatment of ARDS. Controlled clinical trial with the heparin-coated bypass circuit. Int J Artif Organs1992; 15: 103–108.
14.
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators; DaviesAJonesDBaileyM. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA2009; 302: 1888–1895.
15.
TerragniPPDel SorboLMasciaL. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology2009; 111: 826–835.
SlenterRHSprootenRTKotzD. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration2013; 85: 15–26.
IjlandMMHeunksLMvan der HoevenJG. Bench-to-bedside review: hypercapnic acidosis in lung injury–from ‘permissive’ to ‘therapeutic’. Crit Care2010; 14: 237.
20.
BrivaAVadaszILecuonaE. High CO2 levels impair alveolar epithelial function independently of pH. PloS one2007; 2: e1238.
21.
RegaFREvrardVBollenH. pH 48 h after onset of extracorporeal membrane oxygenation is an independent predictor of survival in patients with respiratory failure. Artif Organs2007; 31: 384–389.
22.
WoutersEF. Management of severe COPD. Lancet2004; 364: 883–895.
23.
RobertsCMStoneRABuckinghamRJ. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax2011; 66: 43–48.
24.
HagerDNKrishnanJAHaydenDL. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med2005; 172: 1241–1245.
25.
AbramsDCBrennerKBurkartKM. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc2013; 10: 307–314.
26.
BurkiNKManiRKHerthFJ. A novel extracorporeal CO2 removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPDChest2013; 143: 678–686.
27.
MisakVBBerakovicAPVukusicI. Postintubation tracheal injuries–case series and literature review. Acta Clinica Croatica2012; 51: 467–471.
28.
BangaAKhilnaniGC. Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay. COPD2009; 6: 437–440.
29.
AbramsDBrodieD. Emerging indications for extracorporeal membrane oxygenation in adults with respiratory failure. Ann Am Thorac Soc2013; 10: 371–377.
30.
KlugeSBrauneSAEngelM. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med2012; 38: 1632–1639.
31.
MoenOFosseEDregelidE. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg1996; 62: 1134–1140.
